Peri- und postnatale Depression und ihre Behandlungsmöglichkeiten

ZUSAMMENFASSUNG

Depressive Episoden treten in der Schwangerschaft und postpartal bei etwa jeder zehnten Frau auf und stellen damit eine der häufigsten peri- und postpartalen Erkrankungen dar. Die vorliegende Übersicht stellt die klinische Inzidenz dar. Es werden vorhandene Behandlungsoptionen der peri- und postnatalen Depression vorgestellt und klinisch bewertet. Die meiste klinische Erfahrung besteht in der medikamentösen Therapie und psychotherapeutischen Behandlung. Weniger zugänglich sind die Hirnstimulationsverfahren, die sich aber im Hinblick auf den Schutz des Foetus besonders eignen. Elektrokrampftherapie wird nur im stationären Rahmen durchgeführt. Die repetitive transkranielle Magnetstimulation hingegen eignet sich problemlos im ambulanten Bereich und stellt in Betrachten der spezifischen Risiken eine gut verträgliche und wirksame Behandlungsoption dar.

ABSTRACT

During pregnancy and postpartum in about one in ten women depressive episodes occur, making it one of the most common peri- and postpartum conditions. This overview presents the clinical incidence of depression related to pregnancy. The currently available treatment options for peri- and postnatal depression are introduced and clinically evaluated. Most clinical experience exists in drug therapy and psychotherapeutic treatment. Brain stimulation methods are less accessible, but they are particularly suitable with regard to the protection of the fetus. Electroconvulsive therapy is only performed in an inpatient setting. Repetitive transcranial magnetic stimulation, on the other hand, is easily suitable for outpatient care and, considering the specific risks, represents a well-tolerated and effective treatment option.

Schlüsselwörter

Schwangerschaft - postpartale Depression - perinatale Depression - postnatale Depression - Behandlungsoptionen

Key words

Pregnancy - postpartum depression - perinatal depression - postnatal depression - reatment options

Publikationsverlauf

Artikel online veröffentlicht:
10. Oktober 2024

• Literatur

• 1 Trifu SC, Popescu A, Marian MA. Affective disorders: A question of continuing treatment during pregnancy (Review). Exp Ther Med 2020; 20: 3474-3482
• 2 Josefsson A, Berg G, Nordin C. et al Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gyn Scan 2001; 80: 251-255
• 3 Sharp D, Hay DF, Pawlby S. et al The impact of postnatal depression on boys’ intellectual development. J Child Psychol Psyc 1995; 36: 1315-1336
• 4 Yonkers KA, Wisner KL, Stewart DE. et al The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiat 2009; 31: 403-413
• 5 Wisner KL, Sit DKY, McShea MC. et al Onset Timing, Thoughts of Self-harm, and Diagnoses in Postpartum Women With Screen-Positive Depression Findings. Jama Psychiat 2013; 70: 490-498
• 6 Vesga-Lopez O, Blanco C, Keyes K. et al Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiat 2008; 65: 805-815
• 7 Cox JL, Murray D, Chapman G. A Controlled-Study of the Onset, Duration and Prevalence of Postnatal Depression. Brit J Psychiat 1993; 163: 27-31
• 8 Shorey S, Chee CYI, Ng ED. et al Prevalence and incidence of postpartum depression among healthy mothers: A systematic review and meta-analysis. J Psychiatr Res 2018; 104: 235-248
• 9 Hagatulah N, Bränn E, Oberg AS. et al Perinatal depression and risk of mortality: nationwide, register based study in Sweden. Brit Med J 2024; 384: e075462
• 10 Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Women Ment Hlth 2005; 08: 77-87
• 11 Chen C, Okawa S, Okubo R. et al Mother-to-infant bonding difficulties are associated with future maternal depression and child-maltreatment behaviors: A Japanese nationwide longitudinal study. Psychiat Res 2024: 334
• 12 Liu XY, Wang SH, Wang GP. Prevalence and Risk Factors of Postpartum Depression in Women: A Systematic Review and Meta-analysis. J Clin Nurs 2022; 31: 2665-2677
• 13 Justesen K, Jourdaine D. Peripartum Depression: Detection and Treatment. Am Fam Physician 2023; 108: 267-272
• 14 Cox JL, Holden JM, Sagovsky R. Detection of Postnatal Depression – Development of the 10-Item Edinburgh Postnatal Depression Scale. Brit J Psychiat 1987; 150: 782-786
• 15 McCabe-Beane JE, Segre LS, Perkhounkova Y. et al The identification of severity ranges for the Edinburgh Postnatal Depression Scale. J Reprod Infant Psyc 2016; 34: 293-303
• 16 Becker M, Weinberger T, Chandy A. et al Depression During Pregnancy and Postpartum. Curr Psychiat Rep 2016; 18: 32
• 17 Reangsing C, Punsuwun S, Oerther S. Effects of mindfulness-based interventions (MBIs) on depression in pregnant women: A systematic review and meta-analysis. J Affect Disord 2024; 352: 51-59
• 18 Sari YP, Hsu YY, Nguyen TTB. The Effects of a Mindfulness-Based Intervention on Mental Health Outcomes in Pregnant Woman: A Systematic Review and Meta-Analysis. J Nurs Res 2023; 31: e306
• 19 Sun YL, Dreier JW, Liu XQ. et al Trend of antidepressants before, during, and after pregnancy across two decades-A population-based study. Brain Behav 2019; 09: e01441
• 20 Pariente G, Leibson T, Carls A. et al Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review. Plos Med 2016; 13: e1002160
• 21 Ailes EC, Simeone RM, Dawson AL. et al Using Insurance Claims Data to Identify and Estimate Critical Periods in Pregnancy: An Application to Antidepressants. Birth Defects Res A 2016; 106: 927-934
• 22 Molenaar NM, Bais B, Lambregtse-van den Berg MP. et al The international prevalence of antidepressant use before, during, and after pregnancy: A systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J Affect Disorders 2020; 264: 82-89
• 23 Anderson GD. Pregnancy-induced changes in pharmacokinetics – A mechanistic-based approach. Clin Pharmacokinet 2005; 44: 989-1008
• 24 Uguz F. Neonatal and Childhood Outcomes in Offspring of Pregnant Women Using Antidepressant Medications: A Critical Review of Current Meta-Analyses. J Clin Pharmacol 2021; 61: 146-158
• 25 Suarez EA, Bateman BT, Hernández-Díaz S. et al Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children. Jama Intern Med 2022; 182: 1149-1160
• 26 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, Version 3.0. 2022. doi:10.6101/AZQ/000493
• 27 Kim DR, Epperson N, Paré E. et al An Open Label Pilot Study of Transcranial Magnetic Stimulation for Pregnant Women with Major Depressive Disorder. J Womens Health 2011; 20: 255-261
• 28 Taylor R, Galvez V, Loo C. Transcranial magnetic stimulation (TMS) safety: a practical guide for psychiatrists. Australas Psychiatry 2018; 26: 189-192
• 29 Miuli A, Pettorruso M, Stefanelli G. et al Beyond the efficacy of transcranial magnetic stimulation in peripartum depression: A systematic review exploring perinatal safety for newborns. Psychiat Res 2023; 326: 115251
• 30 O’Reardon JP, Cristancho MA, von Andreae CV. et al Acute and Maintenance Electroconvulsive Therapy for Treatment of Severe Major Depression During the Second and Third Trimesters of Pregnancy With Infant Follow-Up to 18 Months. J Ect 2011; 27: E23-E26
• 31 Coshal S, Jones K, Coverdale J. et al An Overview of Reviews on the Safety of Electroconvulsive Therapy Administered During Pregnancy. J Psychiatr Pract 2019; 25: 2-6
• 32 Grözinger M, Conca A, Nickl-Jockschat T. et al Elektrokonvulsionstherapie kompakt. Berlin: Springer; 2013
• 33 Cox EQ, Sowa NA, Meltzer-Brody SE. et al The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes. J Clin Psychiat 2016; 77: 1189-1200
• 34 Dama MH, Lieshout RJV. Perinatal Depression: A Guide to Detection and Management in Primary Care. J Am Board Fam Med 2023; 36: 1071-1086